Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
323
-
Total 13F shares, excl. options
-
129,903,867
-
Shares change
-
-15,103,995
-
Total reported value, excl. options
-
$2,564,492,170
-
Value change
-
-$263,257,024
-
Put/Call ratio
-
103%
-
Number of buys
-
117
-
Number of sells
-
-132
-
Price
-
$19.73
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2019
373 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2019.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 323 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129,903,867 shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (30,582,721 shares), PAULSON & CO. INC. (13,244,711 shares), Adelphi Capital LLP (8,958,784 shares), VANGUARD GROUP INC (5,977,204 shares), MACQUARIE GROUP LTD (5,109,419 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,109,398 shares), BANK OF AMERICA CORP /DE/ (3,959,252 shares), NORTHERN TRUST CORP (3,745,454 shares), Mondrian Investment Partners LTD (3,639,170 shares), and Parametric Portfolio Associates LLC (3,499,987 shares).
This table shows the top 323 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.